Literature DB >> 2762021

Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

P J Baker, M E Wilson.   

Abstract

Actinobacillus actinomycetemcomitans is a gram-negative bacterium frequently recovered from periodontal lesions of patients with localized juvenile periodontitis (LJP). Elevated levels of serum IgG and IgM antibodies to A. actinomycetemcomitans antigens are frequently observed in LJP patients, although the functional properties of such antibodies have not been characterized systematically. In this study, we analyzed serum from LJP subjects infected with A. actinomycetemcomitans with respect to the presence of IgG antibodies expressing opsonic, bactericidal and/or leukotoxin-neutralizing activity against this organism. The IgG fractions obtained from serum of 3 LJP patients with elevated antibody titers to A. actinomycetemcomitans contained opsonic activity against a non-leukotoxic Y4 strain, as well as for a highly leukotoxic JP2 strain. Opsonic activity required the presence of complement. The IgG fractions of pooled normal serum and serum from a fourth LJP subject with minimal ELISA-reactive IgG antibody against this organism lacked detectable opsonic activity. Leukotoxin-neutralizing IgG antibodies, although variably present, did not influence neutrophil killing of the leukotoxic JP2 strain. None of the sera tested contained bactericidal IgG antibodies capable of promoting direct complement-mediated killing of A. actinomycetemcomitans. These results indicate that LJP subjects infected with A. actinomycetemcomitans are capable of producing opsonic IgG antibodies which may facilitate neutrophil-mediated host defense against this periodontopathic organism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762021     DOI: 10.1111/j.1399-302x.1989.tb00106.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  19 in total

1.  Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibody reactive with phosphorylcholine.

Authors:  Donald Purkall; John G Tew; Harvey A Schenkein
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  The heat-modifiable outer membrane protein of Actinobacillus actinomycetemcomitans: relationship to OmpA proteins.

Authors:  M E Wilson
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Immune response to cytolethal distending toxin of Aggregatibacter actinomycetemcomitans in periodontitis patients.

Authors:  E S Ando; L A De-Gennaro; M Faveri; M Feres; J M DiRienzo; M P A Mayer
Journal:  J Periodontal Res       Date:  2010-03-09       Impact factor: 4.419

4.  Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes.

Authors:  N Yamaguchi; M Kawasaki; Y Yamashita; K Nakashima; T Koga
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

5.  Genetic segregation analyses of serum IgG2 levels.

Authors:  M L Marazita; H Lu; M E Cooper; S M Quinn; J Zhang; J A Burmeister; J V Califano; J P Pandey; H A Schenkein; J G Tew
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

6.  Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  T Y Ling; T J Sims; H A Chen; C W Whitney; B J Moncla; L D Engel; R C Page
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

7.  Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease.

Authors:  J L Ebersole; M N Sandoval; M J Steffen; D Cappelli
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals.

Authors:  H Lu; M Wang; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis.

Authors:  K Sjöström; R Darveau; R Page; C Whitney; D Engel
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Subinhibitory concentrations of cefpodoxime alter membrane protein expression of Actinobacillus actinomycetemcomitans and enhance its susceptibility to killing by neutrophils.

Authors:  P J Baker; W F Busby; M E Wilson
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.